University of Chicago Comer Children's Hospital
University of Chicago Comer Children's Hospital
Chicago, Illinois, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study | Pediatric Solid Tumor | Active, not recruiting | Not stated | 2026-09-21 | NCT02520713 | |
| Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2026-09-04 | NCT01711554 | |
| The PATHway Study: Primary Care Based Depression Prevention in Adolescents | depressive disorder | Active, not recruiting | Not applicable | 2026-06-22 | NCT05203198 | |
| Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2026-03-23 | NCT02573896 |